Get the Stockscreener App
1.04
5.45%
-0.06
After Hours:
2.59
1.55
+149.04%
Dyadic International Inc De stock is traded at $1.04, with a volume of 67,911.
It is down -5.45% in the last 24 hours and down -22.39% over the past month.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
See More
Previous Close:
$1.10
Open:
$1.11
24h Volume:
67,911
Relative Volume:
1.73
Market Cap:
$33.60M
Revenue:
$2.96M
Net Income/Loss:
$-6.87M
P/E Ratio:
-4.5217
EPS:
-0.23
Net Cash Flow:
$-7.49M
1W Performance:
-13.33%
1M Performance:
-22.39%
6M Performance:
-37.72%
1Y Performance:
-45.83%
1-Day Range:
$1.00
$1.1399
1-Week Range:
$1.00
$1.25
52-Week Range:
$1.00
$2.67
Dyadic International Inc De Stock (DYAI) Company Profile
Name
Dyadic International Inc De
Sector
Industry
Phone
561-743-8333
Address
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Downgrade | Dawson James | Buy → Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
Dyadic International Inc De Stock (DYAI) Latest News
Global Hydrolase Enzymes Market Size, Share And Growth Analysis For 2024-2033 - EIN News
Global Protein Hydrolysis Enzymes Market Expected to Hit $ 1.54 Billion by 2032, Growing at 4.9% CAGR - 대구포스트
DYAI stock touches 52-week low at $1.1 amid market challenges - Investing.com
Specialty Enzymes Market Advancements Highlighted by Report, Size, Share, Growth, Trends, Industry Analysis... - WhaTech
Proteases Market In-Depth Analysis, Business Forecast and Dynamics 2023 – (2024-2034) - Apiculture Market: Report ...
[Updated] Wheat Enzyme Market Size Analysis - Economica
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference - StockTitan
Global Alcohol and Starch Enzyme Market Expected to Reach $ 3962.3 Billion by 2032, Growing at a CAGR of 6.5% - 대구포스트
Daiwa America Upgrades Sony Group (NYSE:SONY) to Strong-Buy - Defense World
Proteases Market In-Depth Analysis, Business Forecast and Dynamics 2023 – (2024-2034) - Daily News Mirror
Hydrolase Enzymes Market Report Explores Market Size, Share Analysis, And Outlook To 2033 - WhaTech
Hydrolase Enzymes Market Report Explores Market Size, Share Analysis, And Outlook To 2033 - WhaTech Technology and Markets News
Global Protein Hydrolysis Enzymes Market Size, Regional Demand, Trends and Forecast to 2024-2034 - 대구포스트
Dyadic International (NASDAQ:DYAI) Stock Quotes, Forecast and News Summary - Benzinga
Proteases Market Report Explores 2024: Insights into Growth, Industry Demand, and Technological Advancements - WhaTech
Global Protein Hydrolysis Enzymes Market Forecast, Component, Type, End-User Industries, and Regional Analysis, 2024-2032 - 대구포스트
Protein Hydrolysis Enzymes Market Growth Analysis with Investment Opportunities For 2024-2033 - EIN News
[Trends ] Acid Mannanase Market Growth Drivers - Economica
Alcohol Enzymes Market: Global Size, Share, Trends, Application Analysis and Growth by Forecast to 2031 - openPR
Food Enzymes Market to Hit $3.1 billion by 2026 | Key - GlobeNewswire
Earnings call: Dyadic International focuses on diverse revenue streams By Investing.com - Investing.com UK
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress - GlobeNewswire
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress - Yahoo Finance
Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024 - StockTitan
Alcohol and Starch Enzyme Market is set to Generate Revenue of $3962.3 Billion by 2032 - The NRI News
Food Enzymes Market Size 2024 by Recent Technological Advancemen - WICZ
Cellulase Market Overview And Statistic For 2024-2033 - EIN News
Protein Hydrolysis Enzymes Market to Witness Astonishing Growth by 2032 - The NRI News
Alpha-Amylase Baking Enzyme Market Forecasted To Reach US$ - openPR
Trump Media (NASDAQ: DJT) Soaring After Assassination Attempt; - openPR
Grown Rogue International (OTCMKTS:GRUSF) versus BrasilAgro – Companhia Brasileira de Propriedades Agrícolas (NYSE:LND) Financial Comparison - Defense World
Contrasting Cullinan Therapeutics (NASDAQ:CGEM) and Dyadic International (NASDAQ:DYAI) - American Banking and Market News
Proteases Market to Make Great Impact in Near Future over 2031 Amano Enzyme Inc, Associated British Foods Plc, E. I. du Pont de Nemours and Company, Novozymes A/S, Chr. Hansen Holding A/S – TIMC - TIMC
Alcohol and Starch Enzyme Market 2024-2032 | Size, Share, Trends Analysis by 2032 - The NRI News
SmallCap Tech/Biotech Stocks July/Aug 2024: ZVSA, DYAI, ZVRA, PRSO, RLMD, VTAK, ENTO, INBS, KAVL - openPR
Brokers Offer Predictions for Dyadic International, Inc.’s Q2 2024 Earnings (NASDAQ:DYAI) - Defense World
Protease Market Thrives on Sustainable Food Practices Anticipated to Reach $5.76 Billion by 2030 - EIN News
Investor's Toolkit: Key Ratios for Assessing Dyadic International Inc., DE (DYAI)'s Performance – DWinneX - The Dwinnex
What was Dyadic International Inc., DE (DYAI)’s performance in the last session? - US Post News
Specialty Enzymes Market worth $9.2 billion by 2029 | Key Players - openPR
Specialty Enzymes Market worth $9.2 billion by 2029 | Key Player - News Channel Nebraska
Specialty Enzymes Market worth $9.2 billion by 2029Exclusive Report by MarketsandMarkets - finanznachrichten.de
Highly Efficient Glucoamylase Market Latest Trends &Innovations | Novozymes, DuPont, DSM – Economica - Economica
Roaring Kitty Expands Horizons: Key Stocks to Watch as Influence - WICZ
Dyadic International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure ... - Quantisnow
Dyadic Intl (NASDAQ: DYAI) and Proliant Health Biologicals to La - WICZ
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership - GlobeNewswire Inc.
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership - Yahoo Finance
Phirbo's (PAHC) Dyadic Deal to Fortify Animal Vaccine Wing - Yahoo Movies Canada
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA ... - openPR
Biocatalysis and Biocatalyst Market Poised for Steady Growth, Reaching USD 1290 Million by 2034 with a 6.4% CAGR - Market Research Blog
Dyadic International Inc De Stock (DYAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):